Quarterly Result20 May 2026, 02:39 pm
Eris Lifesciences: FY26 Results; ₹7.21 Dividend (721%)
AI Summary
Eris Lifesciences Ltd's board approved and recorded the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also declared an interim dividend of ₹7.21 per share (721%) for FY26-27, with a record date of May 29, 2026, and payment on or before June 19, 2026. The audit reports are submitted with unmodified opinions.
Key Highlights
- Eris Lifesciences approved audited FY26 financial results.
- Interim dividend of ₹7.21 per share (721%) declared for FY26-27.
- Record date for dividend eligibility is May 29, 2026.
- Dividend payment will be made on or before June 19, 2026.
- Auditor Walker Chandiok & Co LLP issued unmodified opinion on financials.
Price Impact
More from ERIS